InterSystems, a creative data technology provider powering more than one billion health records globally, today announced the successful deployment of InterSystems TrakCare® across iKang Outpatient，the premium healthcare services brand of iKang Healthcare Group. The TrakCare deployment establishes a unified electronic health record (EHR) solution, resolving issues such as data

Median Technologies manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as Medical Devices (SaMD) for the early detection and diagnosis of cancers, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, today announced the signing of a strategic commercial partnership with Canon Medical Systems Corporation through Canon’s subsidiary Olea Medical, marking an important new step in the executio

The MolinaCares Accord (“MolinaCares”), in collaboration with Molina Healthcare of Indiana (“Molina”), announced a $150,000 grant to Indy Reads to develop new curricula that help adult students better understand healthcare — from talking to doctors, to managing health conditions, to encouraging individuals to take an active role in improving their health. People who understand their health information are more likely to follow their treatment plans and

Epitel, Inc., a leader in AI-driven wireless brain health technologies, announced today the closing of a $26 million Series B financing co-led by Catalyst Health Ventures and Genoa Ventures, with participation from new and existing investors. The funding will support the continued market expansion of the company’s REMI® Remote EEG Monitoring System, allowing extended duration wireless EEG monitoring integrated with AI-driven event detection to improve access to neurological care.

Siemens Healthineers announced today that it has launched capillary testing on the Atellica CH, IM, and CI Analyzers after receiving CE-mark for 24 capillary blood testing claims1, an advancement for capillary testing that offers clinical labs greater confidence in test results and higher throughput. Capillary testing on the Atellica analyzers supports the most common laboratory testing needs – including key assays that comprise the comprehensive metabolic panel, lipid panels, thyroid,

EMeRG today announced the launch of its advanced SaaS intelligence platform, built with a mission to make every hospital visible and every MedTech innovation more accessible. Commercial teams often lack visibility into hospital capabilities, installed technologies and adoption potential. Hospital Intel Suite™ bridges that gap by unifying hospital infrastructure, technologies, clinical capabilities and hundreds of intelligence variables into a single platform. The platform is t

LRE Medical will showcase a connected IVD instrument demonstration at ADLM 2026, illustrating how secure connectivity can be engineered into custom diagnostic systems from the earliest stages of development. Visitors will see how embedded software, cloud connectivity and cybersecurity work together within the instrument architecture to enable remote services, lifecycle management and future AI-enabled applications. As diagnostic instruments become increasingly software-defined, conn

BIOTRONIK Neuro today announced the launch of Embrace One® Proactive Intelligence, a proprietary AI capability that advances proactive care for patients implanted with the Prospera® Spinal Cord Stimulation (SCS) System. BIOTRONIK Neuro collects more than 200 data points per patient daily through automatic, objective remote monitoring, and the new AI capability analyzes this data to identify early signals that may indicate a patient could benefit from additional support or therapy opti

RapidPulse, Inc., a medical technology company developing next-generation aspiration technology for the treatment of acute ischemic stroke, today announced the close of a $48 million Series B financing. The raise, which drew substantial investor interest, was co-led by Medtronic, TechWald Next S.p.A., and S3 Ventures. SBI Investment Company Ltd. and Florida Opportunity Fund also joined previous investors Santé Ventures, Syntheon, Hatteras Venture Partners, and Epidarex Capita

Canary Speech, a leader in AI-powered voice biomarker technology, and NeuroLexIQ, The Brain Injury Authority, today announced a strategic partnership to bring objective, voice-based concussion screening into the earliest moment of a personal injury case: the client's first intake call. Mild traumatic brain injuries, or mTBIs, are among the most under-documented injuries in personal injury litigation. Every year, thousands of people walk away from car crashes and falls with concu